KFI
SUPN icon

Key Financial Inc’s Supernus Pharmaceuticals SUPN Stock Holding History

Key Financial Inc’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67K Hold
122
– – ﹤0.01% 993
2026
Q1 		$6.31K Hold
122
– – ﹤0.01% 985
2025
Q4 		$6.06K Hold
122
– – ﹤0.01% 997
2025
Q3 		$5.86K Hold
122
– – ﹤0.01% 1007
2025
Q2 		$3.85K Hold
122
– – ﹤0.01% 1087
2025
Q1 		$4K Hold
122
– – ﹤0.01% 1044
2024
Q4 		$4.41K Hold
122
– – ﹤0.01% 1029
2024
Q3 		$3.8K Hold
122
– – ﹤0.01% 1029
2024
Q2 		$3.26K Hold
122
– – ﹤0.01% 1041
2024
Q1 		$4.16K Hold
122
– – ﹤0.01% 988
2023
Q4 		$3.53K Hold
122
– – ﹤0.01% 1023
2023
Q3 		$3.36K Hold
122
– – ﹤0.01% 1038
2023
Q2 		$3.67K Buy
+122
New +$4.27K ﹤0.01% 1050

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Key Financial Inc's SUPN Position: Q2 2026 in Review

Key Financial Inc held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 122 shares worth $5.67K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Key Financial Inc first reported a position in SUPN in Q2 2023 and has held it in 13 quarters since. The position peaked at $6.31K in Q1 2026. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Key Financial Inc held 122 shares of Supernus Pharmaceuticals worth $5.67K as of Q2 2026.
  • Key Financial Inc left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #993 holding.
  • Key Financial Inc first reported a position in Supernus Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Key Financial Inc's Supernus Pharmaceuticals position peaked at $6.31K in Q1 2026.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.